Monthly News Roundup - January 2017
Trulance Cleared by FDA for Chronic Idiopathic Constipation (CIC)
The U.S. Food and Drug Administration (FDA) has approved Synergy’s Trulance (plecanatide), a uroguanylin analog for the treatment of chronic idiopathic constipation (CIC)....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news